Case Study: Entos Pharmaceuticals builds a modern biotech brand and website with Top Draw

Entos Pharmaceuticals secures $4.2 million with Top Draw

Entos Pharmaceuticals came to Top Draw with the challenge of conveying the power of their groundbreaking Fusogenix gene technology. They needed a modern brand and website to help garner funding for their ambitious work, including the development of a COVID-19 vaccine.

Top Draw created an elevated brand identity and a visually captivating website to demonstrate the impact of Entos' work. The solution successfully helped Entos secure significant funding, including $4.2 million from the Government of Canada and a US$109-million agreement with a biopharmaceutical partner.

Entos Pharmaceuticals